Cartesian Therapeutics Inc (NAS:RNAC)
$ 35.86 1.28 (3.69%) Market Cap: 638.17 Mil Enterprise Value: 519.22 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 50/100

Q2 2020 Selecta Biosciences Inc Earnings Call Transcript

Aug 06, 2020 / 12:30PM GMT
Release Date Price: $75.6 (-9.35%)
Operator

Good morning, and welcome to the Selecta Biosciences Second Quarter 2020 Financial Results and Corporate Update Conference Call. (Operator Instructions) This call is being webcast live on the Investors and Media section of Selecta's website at www.selectabio.com, and it is being recorded.

For opening remarks, I would like to introduce you to Brad Dahms, Chief Financial Officer of Selecta. Please go ahead.

Bradford D. Dahms
Selecta Biosciences, Inc. - CFO, Principal Financial Officer & Principal Accounting Officer

Thank you, operator, and good morning. Welcome to our second quarter 2020 financial results and corporate update conference call. The press release reporting our financial results is available on the Investors and Media section of our website, www.selectabio.com. And our quarterly report on Form 10-Q for the quarter ended June 30, 2020, will be filed later today with the SEC.

Joining me today is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot